Making the choice to implement a new screening tool in your practice can be diffjcult logistically, but the desire to meet client needs often outweighs these hurdles. Screening for perinatal mood and anxiety disorders (PMADs) is part of complete perinatal care as depression is the most common complication of pregnancy. Approximately 20% of women experience depression during the perinatal period, with rates tripling for higher risk groups such as teens and women with low-income (Lancaster, 2010; Robertson, 2004).